Treatment of Pancreatic Cancer With Abraxane

Clinical trial NCT02555813 · COMPLETED

Trial details

NCT number: NCT02555813
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Pancreatic Cancer

Start date: 2015-05-08
Primary completion: 2020-09-07
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.